SMT201600254B
(en)
|
|
PROCEDURE FOR THE PREPARATION OF HYDROMAGNITIS
|
SMT201600118B
(en)
|
|
ANTIGENIC COMPOSITION OF MYCOBACTERIUM
|
IL226477A
(en)
|
|
Salts and polymorphic forms of afatinib
|
SMT201400023B
(en)
|
|
Analogs of buprenorphine
|
BR112012004807A2
(en)
|
|
vaccine for pcsk9
|
SMT201700110B
(en)
|
|
IMMUNOGENIC COMPOSITION
|
DK2348064T3
(en)
|
|
Process for the preparation of polyalkylene glycol derivatives
|
BR112013014429A2
(en)
|
|
starter culture compositions
|
BRPI1005919A2
(en)
|
|
immunogenic composition
|
BRPI0912134A2
(en)
|
|
external preparation for skin
|
SMT201500268B
(en)
|
|
DERIVATIVE OF 5-HYDROXYPIRYMIDIN-4-CARBOSSAMIDE
|
DK2453858T3
(en)
|
|
COURSE OF ACTION
|
DK2609931T3
(en)
|
|
Immunogenic composition
|
IT1402029B1
(en)
|
|
PROCEDURE FOR THE PREPARATION OF ERLOTINIB
|
ITBS20100012A1
(en)
|
|
PROCEDURE FOR THE PREPARATION OF FLUAZINAM
|
DK2462108T3
(en)
|
|
PROCEDURE FOR THE PREPARATION OF PYRAZOLCARBOXYLIC ACIDAMIDS
|
IT1395596B1
(en)
|
|
PROCEDURE FOR THE PREPARATION OF SITAGLIPTIN
|
BR112013014819A2
(en)
|
|
extraction composition
|
FI20115631A0
(en)
|
|
IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF
|
FI20105760A
(en)
|
|
Method and order
|
IT1396530B1
(en)
|
|
ISOLATED THERMAL POOL
|
TH113421B
(en)
|
|
Process for the preparation of alkylines Carbonates and alkyl glycol
|
IT1398273B1
(en)
|
|
PROCEDURE FOR THE PREPARATION OF 14-BROMO DAUNOMICINA
|
TH112358B
(en)
|
|
Process for the preparation of alkyl glycol
|
TH112759B
(en)
|
|
Process for the preparation of alkyl carbonate and / or alkyl glycol.
|